Pinsent Masons represented Teva in the dispute, while Bristows represented Novartis.Teva brought revocation proceedings against two Novartis patents concerning deferasirox, EP 29 64 202 and EP…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now